Your browser doesn't support javascript.
loading
Effects of dapagliflozin in DAPA-HF according to background heart failure therapy.
Docherty, Kieran F; Jhund, Pardeep S; Inzucchi, Silvio E; Køber, Lars; Kosiborod, Mikhail N; Martinez, Felipe A; Ponikowski, Piotr; DeMets, David L; Sabatine, Marc S; Bengtsson, Olof; Sjöstrand, Mikaela; Langkilde, Anna Maria; Desai, Akshay S; Diez, Mirta; Howlett, Jonathan G; Katova, Tzvetana; Ljungman, Charlotta E A; O'Meara, Eileen; Petrie, Mark C; Schou, Morten; Verma, Subodh; Vinh, Pham Nguyen; Solomon, Scott D; McMurray, John J V.
Afiliação
  • Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510 USA.
  • Køber L; Rigshospitalet Copenhagen University Hospital, Blegdamsvej 9, 2100 Copenhagen, Denmark.
  • Kosiborod MN; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, 4401 Wornall Road, Kansas City, MO 64111, USA.
  • Martinez FA; National University of Cordoba, Av.Colon 2057, Cordoba X5003DSE, Argentina.
  • Ponikowski P; Wroclaw Medical University, Borowska 213, Wroclaw 50-556, Poland.
  • DeMets DL; Department of Biostatistics & Medical Informatics, University of Wisconsin, 610 Walnut Street, 250 WARF, Madison, WI 53726, USA.
  • Sabatine MS; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 60 Fenwood Road, Boston, MA 02115 USA.
  • Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden.
  • Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden.
  • Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden.
  • Desai AS; Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
  • Diez M; Division of Cardiology, Institute Cardiovascular de Buenos Aires, Av. Libertador 6302, C1428ART - Buenos Aires, Argentina.
  • Howlett JG; University of Calgary, Cardiac Sciences and Medicine, Room c838, 1403- 29th street NW, Calgary Alberta Canada, T2N2Y9.
  • Katova T; Clinic of Cardiology, National Cardiology Hospital, 65 Konyovitsa Str., Sofia 1309, Bulgaria.
  • Ljungman CEA; Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy, Gothenburg 413 45, Sweden.
  • O'Meara E; Montreal Heart Institute, University of Montreal, 5000 Belanger, Montreal, Quebec H1T1C8, Canada.
  • Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
  • Schou M; Department of Cardiology, Gentofte University Hospital, Herlev Ringvej 75, 2730 Herlev, Denmark.
  • Verma S; Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, 30 Bond Street, Toronto, Canada M5B 1W8.
  • Vinh PN; Department of Internal Medicine, Tan Tao University, Tan Duc Cardiology Hospital, No. 04 Nguyen Luong Bang, Tan Phu Ward, District 7, Ho Chi Minh City 70000, Vietnam.
  • Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
  • McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
Eur Heart J ; 41(25): 2379-2392, 2020 07 01.
Article em En | MEDLINE | ID: mdl-32221582

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores de Angiotensina / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores de Angiotensina / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article